Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0837 vs VKA in Atrial Fibrillation
NCT00684307Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of atecegatran metoxil in Atrial fibrillation (AFib), sponsored by AstraZeneca. Started Feb 2007; status: completed.
02
Drugs
atecegatran metoxil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00684307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684307.